SCHEMBL4039745

SCHEMBL4039745

Nc1ncc(Br)nc1-c1nc2cc(F)c(F)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBFB Q13951 1/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ATR Q13535 14/20 0.43
CYP11B2 P19099 1/20 0.43
CHEK1 O14757 1/20 0.37
PRKDC P78527 1/20 0.36
ATM Q13315 1/20 0.36
PDE10A Q9Y233 1/20 0.36
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4046492 0.89 PDE10A (0.40) CBFBKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL4009740 0.85 METAP2 (0.51) CBFBATR
SCHEMBL4045369 0.85 ATR (0.46) CBFBATRPRKDCATM
SCHEMBL560162 0.79 ATR (0.60) CBFBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL4050888 0.79 NPBWR1 (0.46) CBFBATR
SCHEMBL560241 0.78 ATR (0.68) KDM4EALDH1A1HPGDHSD17B10ATR
SCHEMBL1171206 0.75 ALDH1A1 (0.67) CBFBKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL38658270 0.69 ALDH1A1 (0.69) CBFBKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL14278 0.68 FABP6 (0.59) CBFBKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL1482507 0.67 CBFB (0.56) CBFBKDM4EALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009024825-A1 2-PYRAZINYLBENZIMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed